Liabilities / Assets
24th percentile
Higher debt load relative to assets than 24% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
23rd percentile
Higher debt load relative to revenue than 23% of similar nonprofits.
Net Margin
65th percentile
Higher net margin than 65% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
55th percentile
Faster asset growth than 55% of similar nonprofits.
Revenue Growth
77th percentile
Faster revenue growth than 77% of similar nonprofits.
Balance Sheet
Assets
Up$1,212,870
Up $69,157 (+6.0%) from 2022
Net Assets
Up$1,208,755
Up $69,010 (+6.1%) from 2022
Liabilities
Up$4,115
Up $147 (+3.7%) from 2022
Revenue And Expenses
Revenue
Up$584,224
Up $142,252 (+32%) from 2022
Expenses
Up$515,214
Up $151,517 (+42%) from 2022
Net Income
Down$69,010
Down $9,265 (-12%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview
Mission
Research and development with goal of defining a microvascular index for non-invasive monitoring of vascular health and for early diagnosis of vascular related diseases.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $1,212,870
- Liabilities
- $4,115
- Net assets
- $1,208,755
- Revenue
- $584,224
- Expenses
- $515,214
- Net income
- $69,010